TB
Telos Biotech Inc.
SEC filingBiotechnology · Dallas, TX
Amount raised$725Ksold at filing
Total offering$2.3M$1.5M still open
Investors in the raise4count reported to the SEC
FiledDec 12, 2025first sale Dec 1, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Enzo Ehsan TedoneExecutive Officer, Director
Mohammad Ehsan SayedExecutive Officer, Director
Jerry William ShayExecutive Officer
Sebastian Aguiar BrunemeierDirector
Executive officers, directors and promoters as listed on the Form D.